737 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABT Abbott Laboratories $67.67 $118.71B Sell
Article Searches
A SWAN (Sleep Well At Night) Amid The Swoon? https://seekingalpha.com/article/4212457-swan-sleep-well-night-amid-swoon?source=feed_all_articles Oct 20, 2018 - A good DGI strategy should provide almost everything that most retirees need: decent income, relative safety, and reasonable growth.Our Passive DGI Portfolio has completed its four years anniversary. 
HeartMate 3 gets FDA approval for extended use http://www.startribune.com/business/498061451.html Oct 19, 2018 - Revamped Abbott Labs device is seen as an option for cardiac patients who are unlikely to get transplants.
Heart devices help Abbott Labs meet earnings expectations http://www.startribune.com/business/497818871.html Oct 17, 2018 - After meeting Wall Street quarterly expectations, company looks to 2019.
Abbott Laboratories 2018 Q3 - Results - Earnings Call Slides https://seekingalpha.com/article/4212206-abbott-laboratories-2018-q3-results-earnings-call-slides?source=feed_sector_healthcare Oct 17, 2018 - The following slide deck was published by Abbott Laboratories in conjunction with their 2018 Q3 earnings call.
Abbott Laboratories (ABT) CEO Miles White on Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4212204-abbott-laboratories-abt-ceo-miles-white-q3-2018-results-earnings-call-transcript?source=feed_sector_healthcare Oct 17, 2018 - Abbott Laboratories (NYSE:ABT) Q3 2018 Results Earnings Conference Call October 17, 2018 09:00 AM ET Executives Scott Leinenweber - Vice President, Investor Relations, Licensing and Acquisitions Miles
Abbott Laboratories (ABT) Q3 2018 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2018/10/17/abbott-laboratories-abt-q3-2018-earnings-conferenc.aspx?source=iedfolrf0000001 Oct 17, 2018 - ABT earnings call for the period ending September 30, 2018.
Earnings & Economic Data Deluge http://www.zacks.com/stock/news/328743/earnings-economic-data-deluge?cid=CS-ZC--328743 Oct 17, 2018 - Earnings & Economic Data Deluge
Q3 Earnings Stay (Mostly) Strong, Plus Housing Data http://www.zacks.com/stock/news/328589/q3-earnings-stay-mostly-strong-plus-housing-data?cid=CS-ZC-FT-328589 Oct 17, 2018 - With new Housing Starts, Building Permits and Mortgage Application data, we continue to collect new Q3 earnings results, particularly from UAL, ABT and USB.
Game Plan For The Week - Cramer's Mad Money (10/12/18) https://seekingalpha.com/article/4211578-game-plan-week-cramers-mad-money-10-12-18?source=feed_tag_cramers_picks Oct 15, 2018 - Earnings forecasts will be cut if the Fed keeps raising rates.JPMorgan remains the best of breed among bank stocks.Book profits on W.W Grainger.
Earnings could be what turns the tide for stocks https://www.cnbc.com/2018/10/12/earnings-could-be-what-turns-the-tide-for-stocks.html Oct 12, 2018 - After the wildest market week in months, investors are looking to U.S. corporate earnings season to soothe frayed nerves in the coming week.

Pages: 123456...74

Page 1>

Related Companies

Name Exchange Price Mkt Cap
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
LLY Eli Lilly and Company NYSE $105.71 $113.53B
SNY Sanofi NYSE $43.75 $109.14B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Abbott Laboratories